TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/23 18:30 | 12/26/23 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -39 | 9.24 | 0 | -4 | -4 | 112 | D | |||||||||||||||
6/29/23 16:59 | 6/28/23 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -9 | 11.40 | 0 | -1 | -1 | 116 | D | |||||||||||||||
5/24/23 16:36 | 5/23/23 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -6 | 9.15 | 0 | -1 | -1 | 117 | D | |||||||||||||||
4/26/23 16:23 | 4/25/23 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -8 | 10.59 | 0 | -1 | -1 | 117 | D | |||||||||||||||
3/27/23 16:05 | 3/23/23 | CGEM | Cullinan Oncology, Inc. | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -7 | 10.51 | 0 | -1 | -1 | 118 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |